SARS CoV 2 News and Research

RSS

Interferon response induced by Omicron BA.1 and BA.5 prevents influenza A infection

In a recent study posted to the bioRxiv* preprint server, researchers in Germany and the United Kingdom investigated the interferon responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant and SARS-CoV-2 Omicron sub-variants BA.1 and BA.5, and their efficacy in protecting cells from influenza A virus super-infection.

12 Sep 2022

Self-replicating intradermal RNA vaccine against SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 Sep 2022

Pre-existing psychological distress increases risk of long-COVID

In a recent study published in the Journal of American Medical Association (JAMA) Psychiatry, researchers investigated the association of psychological distress before coronavirus disease 2019 (COVID-19) with the risk of post-acute sequelae of COVID-19 (PASC).

12 Sep 2022

Brain injury a common consequence of both COVID-19 and influenza

In a recent study published in the journal Brain, researchers reported that brain injury is common in coronavirus disease 2019 (COVID-19) and influenza.

12 Sep 2022

A direct side-by-side comparison of all available COVID-19 vaccines

In a recent study posted to the medRxiv* preprint server, researchers assessed immune responses to homologous and heterologous coronavirus disease 2019 (COVID-19) vaccine combinations among Córdoba, Spain residents.

11 Sep 2022

Antibody escape less pronounced with BA.2.75 compared to BA.4/5

In a recent study published in the Lancet, researchers evaluated the antibody neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 subvariant.

11 Sep 2022

Discovery of antibodies that may eliminate the need for COVID vaccines

...

11 Sep 2022

Climate change has increased the risk of bat-borne pathogen spillover

In a recent study posted to the bioRxiv* preprint server, researchers retrospectively assessed the association between climate change and disease spillover risks triggered by bat distribution changes based on historical climate and vampire-bat occurrence data for the previous century (1900-2020).

11 Sep 2022

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

A new study reports SARS-CoV-2 spike antigen and cytokine levels in a sample of infected individuals, of which a subset had long COVID.

11 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

New antiviral treatment may limit the transmission of SARS-CoV-2 virus

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system. With each breath, you expel invisible viral particles into the air - a process known as viral shedding.

9 Sep 2022

New research project investigates molecular mechanisms underlying NeuroCOVID

Infections with the coronavirus SARS-CoV-2 can trigger both temporary and long-term neurological and neuropsychiatric symptoms, severely impacting patients and the wider society.

9 Sep 2022

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.

9 Sep 2022

Individual COVID-19 infections include multiple variants of the SARS-CoV-2 virus, research shows

Researchers at Case Western Reserve University found wide genetic variation in SARS-CoV-2 viruses among 360 patients whose viral infections were genetically sequenced, showing that all individual infections include multiple variants of the virus.

9 Sep 2022

Can cod liver oil supplementation prevent COVID-19 and other acute respiratory infections?

A new study aimed to analyze whether cod liver oil could prevent serious COVID-19, SARS-CoV-2 infection, or other acute respiratory infections during the winter of 2020-2021.

9 Sep 2022

Scientists observe how SARS-CoV-2 protein dismantles critical immunity pathway

Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments.

9 Sep 2022

Respirator masks used by anesthetists associated with 38% increased risk of airway complications in patients

Personal protective equipment (PPE) was rarely out of the news throughout the peaks of the COVID-19 pandemic.

9 Sep 2022

Factors influencing patient’s perception during COVID-19 recovery

A team of researchers characterized individual-level illness perception, both cognitive and emotional, following COVID-19.

9 Sep 2022

COVID-19’s long-term impact on orphanhood and caregiver loss

Researchers performed epidemiologic modeling to update COVID-19-associated caregiver and parent loss estimates.

9 Sep 2022

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

MolGen B.V. of Veenendaal (NL), participates in the 24th Annual Conference of the European Society for Clinical Virology (ESCV) held in Manchester, United Kingdom on 7-10 September 2022.

From AgriGenX 9 Sep 2022